The safety and efficacy of 0*3% ofloxacin in treating bacterial ocular 
Bacterial infection of the outer eye is common, but there is a limited range of antimicrobial agents available for topical therapy. The search for new agents is influenced by the emergence of resistant bacterial strains to some topical preparations and by considerations of local and systemic toxicity.
In the following study the clinical efficacy of ofloxacin, a new antibiotic, was compared with that of chloramphenicol, an agent widely used against external bacterial ocular infections. This comparison was undertaken because chloramphenicol resistance has become established in several pathogens.'2 Moreover, rare but serious reactions have been associated with topical ocular use of chloramphenicol. -5 Ofloxacin, a synthetic fluorinated quinolone first described in 1982, shows promise as an 
